Introduced
by
To authorize an exception to the procedures that govern physicians or pharmacists prescribing or dispensing controlled substances for cases in which an “opioid antagonists” (such as naloxone) are provided for treatment of heroin overdoses.
Referred to the Committee on Health Policy
